We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Polybiome Systems Medicine: Conceptual Architecture, Methodological Foundations, and Translational Applications — Volume I: Vision and Foundational Methodology
AI summary Read the abstract
This foundational document presents the Polybiome Systems Medicine framework, proposing that the human organism is a co-constructed biological consortium shaped by host genomics, multi-kingdom microbiomes, environmental exposures, and immune networks. The framework incorporates environmental factors including microplastics and endocrine disruptors as modulators of human health. The authors outline a five-layer architecture designed to integrate diverse biological data for a more holistic approach to medicine.
This White Paper, titled "Polybiome Systems Medicine: Conceptual Architecture, Methodological Foundations, and Translational Applications — Volume I: Vision and Foundational Methodology," articulates a pioneering constitutional framework for a new paradigm in integrative biomedical science. Authored by Prof. Reyed M. Reyed, this foundational document (Version 0.1) challenges conventional reductionist, host-centric models by positioning the human organism as a complex, co-constructed biological consortium—the Polybiome. The manuscript operationalizes this concept through a rigorous five-layer architecture that cohesively integrates: Layer I: Host Genomic and Epigenomic Core, representing the constitutional blueprint modulated by environmental and microbial signals. Layer II: Multi-Kingdom Microbiota, encompassing bacterial, viral (virome), fungal (mycobiome), and archaeal communities that collectively form the biological hub of host interactions. Layer III: Metabolic and Nutritional Matrix, emphasizing dynamic biochemical signaling and algorithmic nutrition as key regulators of systemic health. Layer IV: Environmental Exposome, systematically mapping external stressors such as pollutants, endocrine disruptors, and nanoplastics that continuously shape biological trajectories. Layer V: AI-Driven Temporal Trajectory, leveraging advanced Digital Twin technologies for continuous monitoring, predictive modeling, and probabilistic forecasting of individual health states. Key Highlights of Volume I include: Methodological Foundations: Establishing four rigorous pillars of causal inference and biological insight—longitudinal cohort tracking, nested deep-phenotyping, adaptive experimental designs (including N-of-1 trials), and intervention-first validation grounded in the Perturbation Model. Biological Sovereignty: Proposing an innovative governance model that secures both individual and national agency over sensitive biological and multi-omic data, employing federated analytics and ethical stewardship to uphold transparency, privacy, and equitable benefit sharing. Strategic Roadmap: Aligning this emergent systems medicine framework with Egypt Vision 2030, advocating for the construction of a national bio-infrastructure that supports AI-native precision medicine. It further outlines the clinical validation pathway for the NexDi system, a cutting-edge tool for precision reclassification of diabetes phenotypes. This manuscript functions as a definitive reference and blueprint for researchers, clinicians, AI scientists, and policymakers who are committed to advancing the frontiers of integrative, predictive, and personalized medicine within a framework that respects data sovereignty and bioethical responsibility.
More Papers Like This
Polybiome Systems Medicine: Conceptual Architecture, Methodological Foundations, and Translational Applications — Volume I: Vision and Foundational Methodology
AI summary Read the abstract
This white paper introduces a theoretical framework called Polybiome Systems Medicine, which views the human body as a complex biological consortium shaped by genomic, microbial, environmental, and immune interactions. The framework includes environmental exposomes such as microplastics and endocrine disruptors as key factors influencing human health. The authors propose a five-layer systems architecture for integrating these diverse biological and environmental inputs into a unified medical model.
Nanoplastics: An Emerging Threat to Human Health—A Perspective Review
AI summary Read the abstract
Researchers propose an 'Exposome–Microbiome–Immune' framework for nanoplastic risk assessment, arguing that validated nanoFTIR and SERS detection, multigenerational animal studies, and longitudinal human cohorts are necessary to shift the field from descriptive toxicology toward systems-level understanding of sub-100 nm plastic hazards.
The Micronanoplastics-immune axis across organ systems: towards a research agenda
AI summary Read the abstract
This review synthesizes current evidence on how micro- and nanoplastics interact with the immune system across multiple organ systems in the human body. Researchers examined the primary routes of exposure through inhalation, ingestion, and dermal contact, as well as the cellular mechanisms involved in immune response. The study highlights that microplastic-immune interactions may contribute to chronic inflammation and immune dysregulation, pointing to a need for standardized research frameworks.
Tackling the microplastics pandemic: the CLEAN framework as an integrated one health approach for global environmental and public health
AI summary Read the abstract
This paper introduces the CLEAN framework as an integrated One Health approach for addressing microplastic pollution across environmental, animal, and human health domains. Researchers argue that current responses to microplastic contamination are fragmented and propose a systematic risk assessment and prevention strategy analogous to occupational health management. The framework aims to bridge gaps between environmental science, public health policy, and community-level action on microplastic exposure.
The Human Plastiphere:A Bioparticulate System ChallengingMicroplastic Risk Assessment and Governance
AI summary Read the abstract
Drawing on 90 clinical studies from 2016–2025, researchers defined the 'human plastiphere' — the system of non-endogenous plastic particles that accumulate, distribute, and interact with human tissues — and proposed a framework for assessing its health risks. The review mapped MP accumulation in over a dozen tissue types and identified mechanisms of cellular and organ-level harm.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.